Home > Inhibitors & Agonists > Apoptosis
Cat. No. Product name CAS No.
DC10657 COTI-2 Featured

COTI-2 is a small molecule candidate anti-cancer drug which can convert mutant p53 to wild-type conformation.

1039455-84-9
DC11726 DS-3032b Featured

DS-3032b is a potent, selective, orally available MDM2-p53 inhibitor with potential antineoplastic activity.

1398568-47-2
DC10400 Ecteinascidin 770

Ecteinascidin 770 (ET-770) is a 1,2,3,4-tetrahydroisoquinoline alkaloid with potent anti-cancer activities; inhibits U373MG cells with an IC50 of 4.83 nM.

114899-80-8
DC3156 Elesclomol (STA-4783) Featured

Elesclomol (STA-4783) is a novel potent oxidative stress inducer that illicits pro-apoptosis events among tumor cells..

488832-69-5
DC9762 Emricasan Featured

Emricasan (IDN-6556, PF-03491390) is a potent irreversible pan-caspase inhibitor.

254750-02-2
DC10742 Ferrostatin-1 (Fer-1) Featured

Ferrostatin-1 is a selective inhibitor of erastin induced ferroptosis with EC50 value of 60 nM.

347174-05-4
DC10522 FIN56 Featured

FIN56 is a specific inducer of ferroptosis.

1083162-61-1
DC10972 Flavokawain B

Flavokawain B is a natural chalcone that can induce apoptosis in androgen receptor-negative, hormone-refractory prostate cancer cell lines (IC50=3-50 uM), via up-regulation of death-receptor 5 and Bim expression.

1775-97-9
DC10447 FX1 Featured

FX1 is a novel specific inhibitor of the B cell lymphoma 6 (BCL6).

1426138-42-2
DC10133 Gambogic Acid Featured

Gambogic Acid activates caspases with EC50 of 0.78-1.64 μM and competitively inhibits Bcl-xl, Bcl-2, Bcl-w, Bcl-B, Bfl-1 and Mcl-1 with IC50 of 1.47 μM, 1.21 μM, 2.02 μM, 0.66 μM, 1.06 μM and 0.79 μM, respectively.

2752-65-0
DCAPI1148 Gossypol

Gossypol

303-45-7
DC10787 GSK2982772 Featured

GSK2982772 is a potent and ATP competitive RIP1 inhibitor with an IC50 of 16 nM.

1622848-92-3
DC9721 GSK2983559 active metabolite Featured

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.

1423186-80-4
DC9733 GSK583 Featured

GSK583 is a Highly Potent and Selective Inhibitor of RIP2 Kinase (RIP2K bing IC50=5 nM; rat in vivo PD IC50 = 50 nM).

1346547-00-9
DC10471 GSK-872 Featured

GSK-872 is a potent and selective RIPK3 (receptor-interacting protein kinase-3) inhibitor.

1346546-69-7
DC1066 HA14-1 Featured

HA14-1 is a nonpeptidic ligand of a Bcl-2 surface pocket with IC50 of~9 μM.

65673-63-4
DC10613 NVP-HDM201(Siremadlin ) Featured

HDM201 is an orally bioavailable human double minute 2 homolog (HDM2) inhibitor with potential antineoplastic activity.

1448867-41-1
DC12045 HS-1371 Featured

HS-1371 is a novel kinase inhibitor of RIP3-mediated necroptosis.

2158197-70-5
DC11128 HS148 Featured

HS148 (DAPK3 inhibitor HS148) is a selective DAPK3 inhibitor with Ki of 119 nM, >10-fold selectivity over Pim kinases..

1892595-16-2
DC11126 HS56

HS56 (Pim-DAPK3 inhibitor HS56) is a potent, dual Pim/DAPK3 inhibitor with Ki of 72 nM (Pim-3) and 315 nM (DAPK3), shows micromolar potency toward Pim-1 and Pim-2 (Ki=1.5 and 17 uM).

922050-57-5
DC11127 HS94 Featured

HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases..

1892594-93-2
DC10361 Iberin Featured

Iberin, a sulfoxide analogue of sulforaphane, is a naturally occurring member of isothiocyanate family. It inhibits cell survival with an IC50 of 2.3 μM in HL60 cell.

505-44-2
Page 3 / Total 22 FirstPrevNextLastGoto